Severe Symptomatic Hypocalcaemia Following High-Dose Oral Ibandronate in a Patient With Prior Thyroidectomy and Metastatic Bone Disease

Daniel Li Tu Chen, Amanda Goldrick, Jerry R. Greenfield

Abstract


Ibandronate is used to treat bony metastatic disease and hypercalcaemia of malignancy. We report the first case of severe hypocalcaemia following oral ibandronate. A 65-year-old woman with widespread sclerotic bony metastases due to breast cancer was commenced on oral ibandronate (50 mg daily). The corrected calcium level decreased from 2.11 mmol/L to 1.38 mmol/L (2.1 - 2.6 mmol/L) accompanied by lower leg muscle cramps 3 weeks after initiation of ibandronate therapy. She had an inappropriately normal PTH level of 6.8 pmol/L (1 - 7 pmol/L) with normal 25-OH vitamin D level of 59 nmol/L and normal magnesium level of 0.88 mmol/L (0.7 - 1.05 mmol/L). There was a history of previous total thyroidectomy for multinodular goitre. Intermittent calcium infusion was required to maintain the corrected calcium level around 1.9 - 2 mmol/L over the next 3 weeks. The patient was discharged on calcium citrate 250 mg tds and calcitriol 0.5 mcg qid with calcium level of 1.96 mmol/L. We conclude that oral bisphosphonates are widely used but rarely associated with symptomatic severe hypocalcaemia. Possible mechanisms in this case include hypoparathyroidism and metastatic bone disease with widespread sclerosis. This case demonstrates that patients may develop symptomatic hypocalcaemia when treated with oral bisphosphonates.




J Endocrinol Metab. 2012;2(2):96-98
doi: https://doi.org/10.4021/jem96w

Keywords


Bony tissue neoplasm; Breast neoplasm; Hypocalcemia; Hypoparathyroidism; Ibandronic acid

Full Text: HTML PDF
 

Browse  Journals  

 

Journal of Clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

 

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

 

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

 

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

 

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 
       
 

Journal of Endocrinology and Metabolism, bimonthly, ISSN 1923-2861 (print), 1923-287X (online), published by Elmer Press Inc.                     
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.jofem.org   editorial contact: editor@jofem.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.